Skip to main content

Table 8 Independent predictors of 30-day death in the statin previous users subset of patients with clinically suspected VAP and tracheal aspirate positive culture

From: Impact of prior statin therapy on the outcome of patients with suspected ventilator-associated pneumonia: an observational study

 

Adjusted hazard ratio

95% CI

P

Age

1.10

1.04-1.20

<0.01

SOFA day-1 value

1.24

1.06-1.46

<0.01

Statin continuation after ICU admission

0.30

0.11-0.81

0.02

  1. VAP, ventilator-associated pneumonia; CI, confidence interval; SOFA, sequential organ failure assessment; ICU, intensive care unit.